- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07434375
Speech Intervention Via Telepractice for Children With Repaired Cleft Palate
Speech Intervention Via Telepractice for Children With Repaired Cleft Palate: Randomized Controlled Trial and Assessment of Speech Production and Perception Skills
The goal of this interventional study is to see if online speech therapy works just as well as face-to-face speech therapy in children with cleft palate. The main purposes are:
To compare the speech accuracy of target sounds in words produced by children with cleft palate between online and face-to-face speech therapy.
To compare the gain in speech accuracy in sentences produced by children with cleft palate between online and face-to-face speech therapy.
To assess whether changes in speech intelligibility are perceived by parents. To explore what kinds of factors influence speech accuracy. To explore speech training accuracy and speech understandability training accuracy during speech therapy sessions in children with CP
Participants will participate in 30-minute speech intervention sessions twice a week for 10 weeks, either in-person or online.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chadley Copeland, MPA, MEd, CCRP
- Phone Number: 8067434752
- Email: chadley.copeland@ttuhsc.edu
Study Locations
-
-
Texas
-
Lubbock, Texas, United States, 79430
- Texas Tech University Health Sciences Center
-
Principal Investigator:
- Sue Ann Lee, Ph.D
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Within the ages 5;0 and 11;11 (years; months) at enrollment and for enrollment duration
- Having normal hearing based on a pure-tone hearing screening at 20 dB HL bilaterally at 500, 1000, 2000 and 4000Hz. Children with a history of hearing loss or children who currently are properly equipped with amplification will be included if they pass the hearing screening
- Having typical nonverbal IQ, language, and socioemotional function as determined by a T-score with no more than -1.5 SD from the mean on Kauffman Brief Intelligence Test-2 (KBIT-2), receptive language of Clinical Evaluation Language Fundamentals-5 (CELF-5 Core Language), and Childhood Autism Rating Scale-2 (CARS-2)
- Having a speech sound disorder as determined by a score ≤ 30th percentile on the Goldman-Fristoe Test of Articulation-3 (GFTA-3)
- Demonstrate a cleft-related or a phonological error on at least one phoneme. For the sound, a cleft-related or a phonological error appears at word-initial phoneme on any two of the following tests; single words on GFTA-3, American English Phrase Samples (AEPS) and Sentence Sample (AESS) on the CAPS-A AM
- Willing to comply with all study procedures and availability for the study duration.
Exclusion Criteria:
- Demonstrates a medically diagnosed sensory or neurological disorder based on parents' report
- Presents with velopharyngeal insufficiency (VPI) due to structural anomalies or an oronasal fistula
- English is not the primary language spoken at home. Bilingual children will not be excluded.
- Children who do not demonstrate cleft speech characteristics.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Telepractice Group
Speech therapy delivered through telepractice modality
|
Children with cleft palate will participate in 30-minute speech therapy sessions twice a week for 10 weeks
|
|
Placebo Comparator: Face-to-Face Group
Speech therapy delivered through face-to-face home health modality
|
Children with cleft palate will receive treatment maintaining the same frequency as the intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in percent correct for the target sound in words during post-treatment in Face-to-Face and Teletherapy interventions
Time Frame: Speech accuracy will be measured two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
We will check speech accuracy using 16 test words or sounds for each target.
To see how much someone improves, we will compare how many they say correctly after therapy to how many they said correctly before therapy.
We calculate improvement by subtracting the number correct before therapy from the number correct after therapy, dividing that number by the total number of attempts, and then multiplying by 100 to get a percentage.
Finally, we will compare the improvement percentages between the group that receives therapy online (telepractice) and the group that receives therapy in person (face-to-face).
|
Speech accuracy will be measured two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in percent correct for the target sound in sentences post-treatment in Face-to-Face and Teletherapy interventions
Time Frame: Speech accuracy will be measured two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
Speech accuracy will be measured using 16 sentences for each target sound or speech goal.
To calculate improvement, we will compare the number of sentences said correctly after therapy to the number said correctly before therapy.
We subtract the "before" score from the "after" score, divide by the total number of attempts, and multiply by 100 to get a percentage improvement.
|
Speech accuracy will be measured two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in percent correct of perception of the target sound in words post-treatment in Face-to-Face and Teletherapy interventions
Time Frame: Accuray of perceiving speech sounds will be administered two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
Perceptual accuracy (how correctly a child hears specific sounds or words) will be measured using 24 words for the target sound.
To calculate improvement, we will compare the number of words correctly identified as correct or incorrect after therapy to the number of words correctly identified before therapy.
We subtract the "before" score from the "after" score, divide by the total number of attempts, and multiply by 100 to get a percentage improvement.
Each child's overall improvement score will then be calculated by averaging their results across targets.
|
Accuray of perceiving speech sounds will be administered two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
|
Change in ratings of the Intelligibility in Context Scale post-treatment in Face-to-Face and Teletherapy interventions
Time Frame: Intelligibility in Context Scale will be administered two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
Functional outcomes (how well a child is understood in everyday situations) will be measured using the Intelligibility in Context Scale (ICS).
This is a short questionnaire completed by parents about how easily their child is understood by different people.
Improvement will be calculated by comparing the parent ratings after therapy to the ratings before therapy.
The difference between these two scores will show how much progress was made.
We will compare results between children who received therapy online (telepractice) and those who received therapy in person (face-to-face).
|
Intelligibility in Context Scale will be administered two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
|
Change in the F-ratio of the 's' and 'sh' consonants post-treatment in Face-to-Face and Teletherapy interventions
Time Frame: Acoustic values (F-ratio) will be assessed two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
We will measure how clearly children distinguish between the "s" sound (/s/) and the "sh" sound (/ʃ/) in different vowel contexts.
To do this, children will repeat made-up words that follow a simple pattern (consonant-vowel-b), such as "soob."
These words will include three different vowels: "ee" (i), "ah" (a), and "oo" (u).
Each word will be said within a short sentence, such as "It's the soob again," during a repetition task.
We will use a sound measurement called an F-ratio to compare the acoustic differences between the "s" and "sh" sounds for each vowel.
This ratio is calculated by comparing the median frequency values of the two sounds within each vowel context.
The overall F-ratio results for all participants combined will then be compared from before therapy (pre-test) to after therapy (post-test) to see whether the contrast between the sounds improved.
|
Acoustic values (F-ratio) will be assessed two times during the study: (1) about 1-2 weeks before therapy begins (this is the starting or baseline visit); (2) about 1 week after therapy ends (this is the final study visit).
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Musculoskeletal Diseases
- Mouth Diseases
- Stomatognathic Diseases
- Nervous System Diseases
- Mental Disorders
- Jaw Diseases
- Neurobehavioral Manifestations
- Jaw Abnormalities
- Maxillofacial Abnormalities
- Craniofacial Abnormalities
- Musculoskeletal Abnormalities
- Stomatognathic System Abnormalities
- Congenital Abnormalities
- Neurodevelopmental Disorders
- Mouth Abnormalities
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Communication Disorders
- Cleft Palate
- Speech Sound Disorder
- Therapeutics
- Patient Care
- Rehabilitation
- Aftercare
- Continuity of Patient Care
- Rehabilitation of Speech and Language Disorders
- Speech Therapy
Other Study ID Numbers
- NIDCR Protocol 23-029-E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The NIH Public Access Policy requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to PubMed Central immediately upon acceptance for publication. This ensures that the public has access to the published results of NIH-funded research.
In addition to disseminating data generated from this study in peer-reviewed journals and professional conferences, an integral part of this proposed research is the plan to share outcomes generated from this study with the public to facilitate clinical practice and research. We will share our data, knowledge, and technical outcomes gained through the completion of the proposed study in compliance with the NIH Data Sharing Policy.
All data to be shared will be de-identified before sharing to ensure that participant's privacy is fully protected. Findings from this research have the potential to be immediately informative to speech-language pathologists, special education teachers, parents, and researchers workin
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cleft Palate Children
-
Old Dominion UniversityChildrens Hospital of the King's DaughtersNot yet recruitingCleft Palate | Cleft Palate Children | Cleft Palates | Cleft Lip Palate | Cleft Lip and Cleft Palate | Cleft Palate Repair | Cleft Lip and/or PalateUnited States
-
UMC UtrechtRadboud University Medical Center; Academisch Medisch Centrum - Universiteit... and other collaboratorsCompletedCleft Lip and Palate | Cleft Palate Children | Cleft Alveolar RidgeNetherlands
-
Karolinska InstitutetRecruiting
-
Instituto de Tecnologia do ParanáNot yet recruitingCleft Lip PalateBrazil
-
Cairo UniversityNewGiza UniversityNot yet recruitingCleft Palate | Cleft Palate, Unilateral, Complete | Cleft Lip, Cleft Alveolus and Cleft Palate | Cleft Palate RepairEgypt
-
Ann & Robert H Lurie Children's Hospital of ChicagoEnrolling by invitation
-
AZ Sint-Jan AVCompletedCleft Palate ChildrenBelgium
-
University GhentResearch Foundation FlandersRecruitingCleft Lip and Palate | Cleft Palate Children | Speech Therapy | Speech Disorders in ChildrenBelgium
-
University GhentResearch Foundation FlandersRecruitingCleft Lip and Palate | Cleft Palate Children | Speech Therapy | Speech Disorders in ChildrenBelgium
-
University Hospital, GhentUniversity GhentRecruiting
Clinical Trials on Speech therapy via teleprace
-
Assistance Publique Hopitaux De MarseilleRecruitingEpilepsy | Temporal Lobe Epilepsy | AnomiaFrance
-
National Taiwan University HospitalRecruitingAutism | Language Delay | Speech Disorders in ChildrenTaiwan
-
Hospital de Clinicas de Porto AlegreCompletedOral Cancer | Intelligibility, Speech | Tongue Cancer | Jaw CancerBrazil
-
Ewha Womans University Seoul HospitalEwha Womans University Mokdong Hospital; National Rehabilitation Center, Seoul...CompletedDysarthria As Late Effect of StrokeKorea, Republic of
-
Klinik ArlesheimUniversity of Bern; Paracelsus-Spital RichterswilCompletedHypertension
-
Johns Hopkins UniversityWithdrawn
-
Riphah International UniversityCompletedAutism Spectrum DisorderPakistan
-
Iran University of Medical SciencesCompletedParkinson Disease | Speech Disorders | Voice DisordersIran, Islamic Republic of
-
Johns Hopkins UniversityCompletedPrimary Progressive Aphasia | PPAUnited States
-
Ewha Womans University Seoul HospitalEwha Womans University Mokdong Hospital; National Rehabilitation Center, Seoul...Not yet recruitingDysarthria As Late Effect of Stroke